The DOI matches its Crossref record.
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Abstract
Type 2 diabetes is associated with increased circulating concentrations of markers of the acute-phase response and interleukin-6 (IL-6). An augmented acute-phase response may be a mechanism which explains many of the clinical and biochemical features of type 2 diabetes and its complications. We sought to confirm that circulating concentrations of the cytokine acute-phase mediators IL-6 and tumour necrosis factor alpha [TNFalpha] are elevated in type 2 diabetes, and investigated blood as a source of cytokines in type 2 diabetes. Blood samples from 20 type 2 diabetic and 17 age-matched healthy subjects were incubated in vitro for 24 hr with and without lipopolysaccharide (LPS) stimulation and secreted cytokines measured. Plasma IL-6 and TNFalpha were significantly increased in type 2 diabetes compared to normal subjects. However, basal production of IL-6 and TNFalpha in cultured diabetic blood was markedly depressed in comparison with non-diabetic samples. IL-6 and TNFalpha production was increased in blood in response to LPS, reaching similar levels in diabetic and non-diabetic subjects, though IL-6 was slightly but significantly higher in controls. We conclude that circulating levels of IL-6 and TNFalpha are increased in type 2 diabetes but there is downregulation of basal cytokine production in blood cells in type 2 diabetes. Blood has the capacity to produce cytokines in diabetes which contribute to the augmented acute-phase response, but the main source of the increased plasma IL-6 and TNFalpha concentrations may be from non-circulating cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interleukin-6 is produced by many cell types including macrophages, adipose cells, and skeletal muscle, and circulating levels are increased in type 2 diabetes (53,54).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [54]
In the citing paper
“Interleukin-6 is produced by many cell types including macrophages, adipose cells, and skeletal muscle, and circulating levels are increased in type 2 diabetes (53,54).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [54]
Citations
Cited by
Sorted by citations
Items 401–500 of 566
Neuroendocrine Regulation of Natural Immunity
Berczi, I. (2005) · Neuroimmune biology · doi:10.1016/s1567-7443(05)80017-1 · Cited by 9
Muhammad, S. A., Ashfaq, H., Zafar, S., Munir, F., Jamshed, M. B., Chen, J. Y., & Zhang, Q. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00279-w · Cited by 8
Alexander, E. (2013) · InTech eBooks · doi:10.5772/55634 · Cited by 9
“…and diabetic pregnancies indicates that increased leptin synthesis in GDM is associated with a higher production of proinflammatory cytokines, e.g. IL-6 and TNFα causing a chronic inflammatory environment that enhances leptin production (Pickup et al 2000, Winkler et al 2002, Gao et al 2008).”
BackgroundHong, Y. J., Han, H., Jeong, Y., Jeong, J., Lim, S.-N., Choi, H. J., Jeon, H., Oh, T. K., Lee, S.-J., & Lee, K. H. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.3.288 · Cited by 8
“Hyperglycemia affects all major components of the innate immunity system and impairs the body’s ability to combat infection [22].”
BackgroundJohar, H., Spieler, D., Bidlingmaier, M., Herder, C., Rathmann, W., Köenig, W., Peters, A., Kruse, J., & Ladwig, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132751 · Cited by 9
“Meta-analytic results indicate that IL-6 is the most sensitive inflammatory marker that predicts subsequent diabetes in initially healthy samples [10], and concentrations of IL-6 are elevated in patients with type 2 diabetes [13].”
BackgroundBeltrán-Camacho, L., Jiménez-Palomares, M., Sánchez-Gomar, I., Rosal‐Vela, A., Rojas-Torres, M., Eslava-Alcón, S., Alonso-Piñero, J. A., González-Rovira, A., Extremera-García, M. J., Conejero, R. C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091147 · Cited by 8
Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease
Steele, C. N., & Nowak, K. L. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2010013 · Cited by 8
Insulin Resistance Heralds Positive Cultures after Severe Injury
Mowery, N. T., Carnevale, R. J., Gunter, O. L., Norris, P. R., Dossett, L. A., Dortch, M. J., Morris, J. A., & May, A. K. (2009) · Surgical Infections · doi:10.1089/sur.2008.086 · Cited by 8
Specchia, C., Scott, K. E., Fortina, P. M., Devoto, M., & Falkner, B. E. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00055.x · Cited by 8
Islam, H., Jackson, G. S., Boultbee, J., Tsai, S., Moreno‐Cabañas, A., Teixeira, A. A. D. S., Wright, D. C., Mui, A., & Little, J. P. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00124.2025 · Cited by 8
Begolli-Stavileci, G., Begolli, G., & Begolli, L. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.3199 · Cited by 8
“Tumor necrosis factor-α (TNF-α), as an important inflammatory factor, has been shown to play a central role in the pathogenesis of diabetes [10].”
BackgroundNarasimhulu, C. A., & Singla, D. K. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0596 · Cited by 9
Liu, X., Wang, X.-R., Ma, H.-Z., & Zhang, W. (2022) · Frontiers in Nephrology · doi:10.3389/fneph.2022.1006506 · Cited by 9
Al‐Rawaf, H. A., Alghadir, A. H., & Gabr, S. A. (2021) · BioMed Research International · doi:10.1155/2021/7453000 · Cited by 7
Tang, W., Zhan, J., Li, S., Liu, Y., & Ho, C. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.04.013 · Cited by 7
Abazid, R. M., Kattea, M., Sayed, S., Saqqah, H., Qintar, M., & Smettei, O. A. (2015) · Avicenna Journal of Medicine · doi:10.4103/2231-0770.160242 · Cited by 7
Natural Immunity – Effect of Exercise
Pedersen, B. K. (2005) · Neuroimmune biology · doi:10.1016/s1567-7443(05)80018-3 · Cited by 7
Type 2 Diabetes, Immunity and Cardiovascular Risk: A Complex Relationship
Pedicino, D., Francesca, A., Alessandro, V., Trotta, F., & Liuzzo, G. (2012) · InTech eBooks · doi:10.5772/50611 · Cited by 7
“These pathways are all involved in the development of atherosclerosis and plaque progression/destabilization in diabetic patients. markers such as CRP and IL-6 are elevated in these subjects compared with non-diabetic controls (Katsuki et al., 1998; Pickup et al., 2000; Winkler et al., 1998).”
BackgroundMetabolic Syndrome and C-Reactive Protein in American Adults: The Impact of Abdominal Obesity
Okosun, I. S. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0040 · Cited by 7
Jefferies, C., Hofman, P. L., Keelan, J. A., et al. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00038.x · Cited by 7
Kallel, A., Ftouhi, B., Jemaa, Z., Mahjoubi, I., Feki, M., Slimane, H., Jemaa, R., & Kaabachi, N. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.015 · Cited by 7
Medical Complications Resulting from Severe Obesity
Kastanias, P., Mackenzie, K., Robinson, S., & Wang, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-42536-8_5 · Cited by 9
Wirtz, P. H., von Känel, R., Kunz-Ebrecht, S., Ehlert, U., & Fischer, J. E. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.11.024 · Cited by 7
“, 2000) or smoking-induced elevation in basal TNF-a levels (Mikuniya et al., 1999; Pickup et al., 2000).”
BackgroundResultInfluentialBohara, S., Bagheri, A., Ertugral, E. G., Radzikh, I., Sandlers, Y. I., Jiang, P., & Kothapalli, C. R. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00457-w · Cited by 7
“T2DM has been linked to immune system disorders as well as elevated levels of IL-6, IL-18, MCP-1, and TNF-α [51–53].”
BackgroundPhyto-chemistry and Therapeutic Potential of Natural Flavonoid Naringin: A Consolidated Review
Sheikh, K. H. A., Haokip, S. W., Hazarika, B. N., Devi, O. B., Lian, H. N., Yumkhaibam, T., Ningombam, L., & Singh, Y. D. (2025) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-025-3826-9 · Cited by 6
“(134) These inflammatory cytokines, particularly TNF-(cid:160) , contribute to the worsening of insulin sensitivity, leading to elevated plasma glucose levels.”
Etiopathogenesis of insulin resistance
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820234-0.00010-x · Cited by 7
Increased expression of serum IL-18 and IL-18R in newly diagnosed type 2 diabetes mellitus
Abhilasha, A., Mitra, P., Suri, S., Saxena, I., Shukla, R. K. G., Shukla, K. K., & Sharma, P. (2023) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03271-x · Cited by 6
Regulation of adenosine receptors expression in rat B lymphocytes by insulin
Sakowicz‐Burkiewicz, M., Kocbuch, K., Grdeń, M., Szutowicz, A., & Pawełczyk, T. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22417 · Cited by 6
“…demonstrated that peripheral blood mononuclear cells from diabetic patients are reduced in their ability to produce cytokines [Kaye et al., 1986; Pickup et al., 2000] and the proliferative response of T cells to primary protein antigens are significantly reduced [Eibl et al., 2002]. rant…”
BackgroundLeyvi, G., Vivek, K., Sehgal, S., Warrick, A. B., Moncada, K. A., Shilian, N., Leff, J., Michler, R. E., & DeRose, J. J. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.04.045 · Cited by 6
Ferreira, A. P., Ferreira, C. B., Souza, V. C., et al. (2011) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(11)70112-6 · Cited by 6
Mohamed, F., Raal, F. J., Mbelle, M., Zamparini, J. M., Venturas, J., Shaddock, E. J., Diana, N. E., Mer, M., Dingezweni, S., Bolon, S., et al. (2020) · Wits Journal of Clinical Medicine · doi:10.18772/26180197.2020.v2n3a1 · Cited by 7
Stem Cells Targeting Inflammation as Potential Anti-aging Strategies and Therapies
Gonzalez, Woynarowski, D., & Geffner, L. (2015) · Cell & Tissue Transplantation & Therapy · doi:10.4137/cttt.s19477 · Cited by 6
Bah, T. M., Davis, C. M., Allen, E. M., Borkar, R. N., Perez, R., Grafe, M. R., Raber, J., Pike, M. M., & Alkayed, N. J. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106850 · Cited by 6
Saha, D., Dutta, P., Rebello, K. R., Shankar, A., & Chakraborty, A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05236-9 · Cited by 5
The immune response after stimulation with wall components of gram-positive bacteria and fungi
Tsigou, E., Aloizos, S., Pavlos, M., et al. (2014) · Immunology Letters · doi:10.1016/j.imlet.2013.12.014 · Cited by 5
Ziv, E., Weiss, L., Itamar, R., Patlas, N., Yekhtin, Z., & Gallily, R. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.21005 · Cited by 5
“Several investigators have shown significant increased in pro-inflammation cytokines such as IL6, TNF-α and glucose intolerance [1-3].”
BackgroundSolis-Cano, D. G., Porchia, L. M., González-Mejía, M. E., Pérez-Fuentes, R., Ruiz‐Vivanco, G., Nieva-Vázquez, A., & Torres‐Rasgado, E. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.07.040 · Cited by 5
Ramon, P., Sparks, J., & Omoruyi, F. O. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2020.0078 · Cited by 5
“Data from this study indicated that a combinatorial preparation of K. pinnata and metformin treatment signifi-cantly decreases cellular viability on days 5–7 for HSMM and DHSMM cells.”
Anastasiou, G., Hatziagelaki, E. E., & Liberopoulos, E. N. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001011 · Cited by 6
Risco de distúrbio glicêmico em mulheres idosas ajustado por antropometria e genótipos de citocinas
Ferreira, A. P., Ferreira, C. B., Souza, V. C., et al. (2011) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302011000500016 · Cited by 5
Kao, C.-C., Lian, J. ‐., Chou, M.-Y., Chang, H., & Yang, S. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.06.032 · Cited by 5
PLATELET FUNCTION IN DIABETES MELLITUS
Yngen, M. (2005) · Cited by 5
Ojo, O. A., Ogunlakin, A. D., Ajayi-Odoko, O. A., Gyebi, G. A., Ayokunle, D. I., Olanrewaju, A. A., Agbeye, O. D., Ogunwale, E. T., & Adeyemı, O. S. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04980-1 · Cited by 4
Feng, L., & Gao, L. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70098 · Cited by 5
“Renal inflammation is key pathophysiology of diabetic nephropathy, increased levels of pro ‐ inflammatory cytokines were diagnosed in the diabetic patients [38, 39].”
Wilson, M., Hamid, A. A., Abbas, I. I., Birkett, J. W., Khan, I., Harper, M., Al‐Jumeily, D., & Assi, S. A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15593 · Cited by 7
Screening type 2 Diabetes mellitus among Indians using inflammatory biomarkers
Arif, M., Nigoskar, S., Verma, M., & Amir, A. H. (2024) · Bioinformation · doi:10.6026/973206300200515 · Cited by 4
Çöçelli, L. P., Dıkensoy, E., Çiçek, H., Ibar, Y., Kul, S., & Balat, Ö. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2241-6 · Cited by 4
“On the other hand, those proinflammatory cytokines, including CRP, tumor necrosis factor-alpha (TNF-a), interleukin-6 (IL-6), and IL-8, through their ability to interfere with insulin signaling, can contribute to the development of insulin resistance and the disturbances of glucose metabolism [16, 17].”
BackgroundCirculating interleukins (IL6)-An early predictor of insulin resistance
Porwal, N. B., Ghildiyal, A., Singh, S., Bhattarcharya, S., Iqbal, B., Tiwari, S., & Singh, K. (2016) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v7i6.15250 · Cited by 4
IL-1β and IL-1Ra Variant Profiles in Turkish Patients with Diabetic Peripheral Neuropathy
Nursal, A. F., İnanır, A., Rüstemoğlu, A., Kaya, S. U., Şahin, K., & Yığıt, S. (2018) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666181022165048 · Cited by 4
Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
Zhang, Q., Yang, M., Xiao, Y., Han, Y., Yang, S., & Sun, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191108160643 · Cited by 4
Telikani, Z., Sheikh, V., Zamani, A., Borzouei, S., Salehi, I., Amirzargar, M. A., & Behzad, M. (2020) · کومش · doi:10.29252/koomesh.22.1.71 · Cited by 4
“[27] Pickup JC, Chusney GD, Thomas SM, Burt D.”
BackgroundHoriya, M., Anno, T., Shigemoto, R., Koyama, K., Kawasaki, F., Tomoda, K., Kaku, K., & Kaneto, H. (2022) · Medicine · doi:10.1097/md.0000000000029119 · Cited by 4
Effects of aging and type 2 diabetes on cardiac structure and function: Underlying mechanisms
Nguyen, J. P., Ramírez‐Sánchez, I., Garate‐Carrillo, A., Navarrete-Yañez, V., Carballo-Castañeda, R. A., Ceballos, G. M., Moreno‐Ulloa, A., & Villarreal, F. J. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112108 · Cited by 4
Patel, B. K., Patel, K. H., & Moochhala, S. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.170 · Cited by 5
Elmeazawy, R. Z., Shall, S. I. E., AbdElsamea, M. Z., et al. (2024) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-024-00290-2 · Cited by 4
“It was intended to represent the equilibrium of the host’s inflammatory and immunological status, which might predict the outcome in patients with various diseases [8].”
BackgroundJiffri, E. H. (2017) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2017.05.555669 · Cited by 4
“Diabetes is a group of metabolic diseases that leads to impaired wound healing [5], higher susceptibility to infections [6] atherosclerosis [7], micro-and macrovascular alterations [8] even with optimal glycemic control [9], however poor diabetic control is usually associated with many co-morbidities due to systemic i…”
BackgroundKhalifa, A. S., Elshebiny, A., Eed, E. M., Elhelbawy, M. G., & Rizk, S. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101678 · Cited by 4
Pathophysiology of Diabetes in Obesity
Soodini, G. R., & Hamdy, O. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_7 · Cited by 4
Fenofibrate ameliorates ocular surface inflammation in diabetic keratopathy
Mansoor, H., Lee, I. X. Y., Liu, C., Yu, M., Toh, C. J. L., Hsu, V. W.-T., Liu, F., Lu, D., Lam, T. C., Tan, H. C., et al. (2025) · The Ocular Surface · doi:10.1016/j.jtos.2025.05.010 · Cited by 3
Investigation of the Effects of Saxagliptin in In Vitro and In Vivo Models of Diabetic Neuropathy
Öz, S., Orhan, S. U., Taslidere, A., Özcan, M., & Tekin, S. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70653 · Cited by 3
콩 이소플라본 첨가 아이스크림이 제2형 당뇨모델 마우스의 당뇨 지표에 미치는 영향
양선희, & 최영선 (2014) · Cited by 3
Antidiabetic and Antihypertensive Properties of Naringin: A Review
Ghosh, S., Sarkar, S., Mistry, J., et al. (2023) · International Journal of Zoological Investigations · doi:10.33745/ijzi.2023.v09i01.019 · Cited by 3
“Furthermore, IL-6 and TNF-a concentrations were found to be higher in people with insulin resistance and type 2 diabetes in various investigations (Kado et al., 1999; Pickup et al., 2000).”
BackgroundImmunological factors and placentation: implications for pre-eclampsia
Redman, C. W. G., & Sargent, I. L. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545634.008 · Cited by 3
Sultan, S. (2021) · SAGE Open Medicine · doi:10.1177/20503121211026832 · Cited by 3
Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform
Harrison, S. P., Baumgarten, S., Chollet, M. E., Stavik, B., Bhattacharya, A., Almaas, R., & Sullivan, G. J. (2024) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.12195 · Cited by 3
Satoh, E., & Iwasaki, R. (2010) · The Journal of Physiological Sciences · doi:10.1007/s12576-010-0117-8 · Cited by 3
Carbohydrate Provision in the Era of Tight Glucose Control
Miller, K. R., Lawson, C. M., Smith, V., & Harbrecht, B. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0204-x · Cited by 2
“Increased circulating levels of inflammatory cytokines such as IL-6 and tumor necrosis factor α (TNF-α) have been observed in diabetic patients [5].”
BackgroundHu, W., Han, W., Jiang, Y., et al. (2011) · Preventive Nutrition and Food Science · doi:10.3746/jfn.2011.16.3.242 · Cited by 3
Chang, H., Park, H., Jeong, J., & Lee, W.-L. (2011) · Journal of Life Science · doi:10.5352/jls.2011.21.8.1176 · Cited by 3
“또한 혈장수 준의 높은 TNF-α나 IL-6와 같은 전염증성 사이토카인 발현은 인슐린 저항성이나 대사증후군과 밀접한 상관을 보여 이에 대한 추후 연구와 지방조직에서의 전염증성 마커에 대한 연구 도 필요하다고 사료된다[17,23,30].”
In vitro mononuclear cell production of tumour necrosis factor-α and weight loss
Morris, A., Noakes, M., & Clifton, P. M. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.09.012 · Cited by 3
Bays, H. E., Mandarino, L. J., & DeFronzo, R. A. (2004) · Cited by 3
Soleimani, A., Soleimani, M., Farzadnejad, F., & Tamadon, M.-R. (2020) · Journal of Nephropathology · doi:10.34172/jnp.2020.39 · Cited by 3
“In normal mode, the plasma level of TNF-α is 3-30 pg/mL; in addition, with the progress of nephropathy, the plasma levels of inflammatory molecules that contain pro-inflammatory cytokines increased in diabetic patients (24-26).”
BackgroundSlowing Cardiovascular Disease Progression in African‐American Patients: Diabetes Management
Gavin, J. R. (2004) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2004.03561.x · Cited by 3
Neurohormonal mechanisms in insulin resistance and type 2 diabetes
Lindmark, S. (2004) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3
Advances in SGLT-2 Inhibitors in the Treatment of Diabetic Nephropathy
邹, 维. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151119 · Cited by 2
Zhang, K., Geng, M., & Zhang, P. (2025) · Medicine · doi:10.1097/md.0000000000041688 · Cited by 2
“[33–36] The primary etiology of OM is attributed to Staphylococcus aureus, which produces adhesions facilitating its attachment to both cartilage and surgically implanted medical devices.”
Mohammadzaheri, F., Sheikhhossein, F., Hemmati, A., Ghoreishy, S. M., Sartang, M. M., Shiraseb, F., & Keshavarz, S. A. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01138-7 · Cited by 2
Wang, T., Gong, B., Shi, K., Hu, G., Sun, L., & Xu, Y. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120702 · Cited by 3
Gundrathi, S. G., Sanapalli, B. K. R., Deshpande, A., & Sanapalli, V. (2026) · Journal of Interferon & Cytokine Research · doi:10.1177/10799907261418982 · Cited by 2
“In addition, TNF-a promotes lipolysis in adipose tissue, thereby increasing circulating free fatty acids, which further exacerbate insulin resistance (Duncan et al., 2003; Pickup et al., 2000).”
Zhang, Y., Guo, D., Zhou, Y., Wang, C., Su, G., Huang, J., Wan, Y., Zhang, H., Wan, H., Bo, L., et al. (2026) · Biomarker Research · doi:10.1186/s40364-026-00948-6 · Cited by 4
“Chronic inflammation is closely associated with a wide range of adverse health outcomes and has been implicated in the pathogenesis of malignancy [172], diabetes [173], cardio-vascular disease [174], gastrointestinal disorders [175], Parkinson’s disease [176], and age-related syndromes [177].”
Effect of local and systemic inflammation on gingival mesenchymal stem cells
Kweh, T. J., Tham, R. Y., Gu, J. Y., et al. (2018) · Journal of Advanced Periodontology & Implant Dentistry · doi:10.15171/jpid.2016.011 · Cited by 2
“A chronic low-grade inflammation exists in patients with T2DM(18) and epidemiological studies have reported an increase in plasma levels of inflammatory markers like CRP, IL6 and TNF-α in T2DM patients.(19,20) Hyperglycaemia in diabetes leads to increased non-enzymatic protein glycation and the formation of advanced g…”
BackgroundCodazzi, V., Salvatore, V., Ragogna, F., Marzinotto, I., Anselmo, A., Baldoni, N., Pastore, M. R., Martinenghi, S., Stabilini, A., Bosi, E., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02497-x · Cited by 3
“Specifically, TNF-α and IL-6, which have been reported to be elevated in individuals with obesity or T2D [43 ], were not found to be significantly increased in the high-H group.”
Gooding, K., Spyer, G., Tooke, J., & MacLeod, K. M. (2007) · Practical Diabetes · doi:10.1002/pdi.1179 · Cited by 2
Could Helicobacter pylori Infection Impair Glucose Tolerance in Obese Non-diabetic Subjects?
Rizk, E. M., Mashaly, M. E.-S., Zakaria, S., Abdel‐Razik, A., & Abbas, N. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2016/20484 · Cited by 2
Uysal, E. (2020) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2020.311 · Cited by 2
“Besides the acute phase, IL-6 signalling is thought to be associated with chronic complications of uncontrolled DM such as diabetic nephropathy and sepsis (4, 18, 19).”
BackgroundEffects of Glucose Control on Hematological Indices in Patients with Diabetes Mellitus
Varım, C., Kaya, T., Nalbant, A., UÇAR, A., & Tamer, A. (2014) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2014.015 · Cited by 2
Qureshi, N., Desousa, J., Siddiqui, A. Z., Drees, B. M., Morrison, D. C., & Qureshi, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032732 · Cited by 2
Jafari-Rastegar, N., Hosseininia, H. S., Mousavi-Niri, N., Khakpai, F., & Naseroleslami, M. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385251271231018104311 · Cited by 2
Drug-eluting stent in diabetes
Júnior, H. P. D. L., Atallah, Á. N., & Gomes, W. J. (2007) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802007000500001 · Cited by 2
Role of theranostics in targeting inflammation in chronic diseases
Chandran, C. S., Raj, A., Sourav, K., & Swathy, K. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00002-4 · Cited by 1
Introduction to Cytokine and Chemokine Networks
Mir, M. A., Jan, A., & Sofi, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-4657-0_1 · Cited by 11
Kaczmarek, I., Schüßler, K., Lindhorst, A., Gericke, M. T., & Thor, D. (2025) · Cells · doi:10.3390/cells14110837 · Cited by 1
“Tnf α serum levels are increased in patients with obesity [47] or type 2 diabetes [47,48], leading to reduced insulin sensitivity [49] and adiponectin secretion [50,51].”
Garcia, B. F., Fonseca, F. A. H., Izar, M. C. D. O., Szarf, G., Galhardo, A., Pinto, I. M. F., Caixeta, A. M., Barbosa, A. H. P., Bianco, H. T., & BATTLE-AMI. investigators (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01738-0 · Cited by 1
El‐Dakroury, W. A., Mageed, S. S. A., Raouf, A. A., Ishak, N. W., Danial, M. S., Salah, S. E., Kabil, A. M., Haider, A. A., shaheed, M. R. A., & Said, A. R. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108483 · Cited by 1
Nogueira‐Machado, J. A., Volpe, C. M. O., Abreu, L. F. M., et al. (2014) · Journal of Endocrinology and Diabetes Mellitus · doi:10.12970/2310-9971.2014.02.03.4 · Cited by 1
“br and serum amyloid A, sialic acid, leucocyte count, ROS (reactive oxygen species) production, cytokines (IL-1 , IL-6, TNF- , HMGB-1) and chemokines (CCL2, CCL3, CXCL8) [1-8].”
BackgroundEffects of Glucose Control on Hematological Indices in Patients with Diabetes Mellitus
(2014) · Macedonian Journal of Medical Sciences · doi:10.3889/mjms.1857-5773.2014.0361 · Cited by 1
THE EFFECT OF METFORMIN 0N CYTOKINES IN IRAQI PATIENTS WITH TYPE 2 DIABETES
Yasser, M. K., R, A. M., & Saba, H. (2013) · Innovare Academic Sciences Pvt Ltd - Innovare Journal of Medical Sciences · Cited by 1
Walker, A. K., Dantzer, R., & Kelley, K. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_6 · Cited by 1
Elseweidy, M. M., El-Swefy, S. E., & Shawky, M. (2013) · Biomedical Engineering Research · doi:10.5963/ber0204003 · Cited by 1
“TNF-α is a multifunctional regulating cytokine involved in the inflammatory response in diabetes [5, 6].”
BackgroundHruby, Z. W., & Sowiński, D. (2003) · Advances in Clinical and Experimental Medicine · Cited by 1
Metadata
- Authors
- Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D.
- Affiliations
- Guy's Hospital (GB)
- Corresponding author
- Pickup, John C.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 67
- Issue
- 3
- Pages
- 291-300
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2084483597
- Cited by
- 566
- References
- 0
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 18 · 2023: 21 · 2022: 13 · 2021: 23 · 2020: 26 · 2019: 20 · 2018: 20 · 2017: 17 · 2016: 24 · 2015: 25 · 2014: 35 · 2013: 29 · 2012: 21
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Bupa Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- type 2 diabetes, interleukin-6, TNF-α, acute phase response, lipopolysaccharide stimulation, plasma cytokines, cytokine downregulation, inflammation in diabetes
- MeSH terms
- Acute-Phase Reaction, Diabetes Mellitus, Type 2, Female, Humans, Immunoenzyme Techniques, Lipopolysaccharides, Male, Middle Aged, Tumor Necrosis Factor-alpha, Interleukin-6, N-Acetylneuraminic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review